Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ro 40-7592, a COMT inhibitor, plus levodopa in Parkinson's disease.

× No keyword cloud information.

8 in total

Review 1. Parkinson's disease.

Authors: J R Playfer
Journal: Postgrad Med J Date: 1997-05 Impact factor: 2.401

2. Parkinson's disease.

Authors: D Mukherjee; I R Hastie
Journal: Postgrad Med J Date: 1995-04 Impact factor: 2.401

3. Effect of monoamine oxidase A and B and of catechol-O-methyltransferase inhibition on L-DOPA-induced circling behavior.

Authors: M J Heeringa; F d'Agostini; P DeBoer; M DaPrada; G Damsma
Journal: J Neural Transm (Vienna) Date: 1997 Impact factor: 3.575

Review 4. Clinical pharmacology, therapeutic use and potential of COMT inhibitors in Parkinson's disease.

Authors: S Kaakkola
Journal: Drugs Date: 2000-06 Impact factor: 9.546

5. Clinical Potential of Catechol-OMethyltransferase (COMT) Inhibitors as Adjuvants in Parkinson's Disease.

Authors: P T Ménnistó
Journal: CNS Drugs Date: 1994-03 Impact factor: 5.749

6. Pharmacokinetic-pharmacodynamic interaction between the COMT inhibitor tolcapone and single-dose levodopa.

Authors: J Dingemanse; K Jorga; G Zürcher; M Schmitt; G Sedek; M Da Prada; P Van Brummelen
Journal: Br J Clin Pharmacol Date: 1995-09 Impact factor: 4.335

7. Synergistic interactions between COMT-/MAO-inhibitors and L-Dopa in MPTP-treated mice.

Authors: A Fredriksson; T Archer
Journal: J Neural Transm Gen Sect Date: 1995

Review 8. Catechol-O-methyltransferase inhibitors for levodopa-induced complications in Parkinson's disease.

Authors: K H O Deane; S Spieker; C E Clarke
Journal: Cochrane Database Syst Rev Date: 2004-10-18

8 in total